TRAF2 and colorectal carcinoma: Liquidambaric acid (LDA), a natural compound, disrupts the interaction between TNF receptor-associated factor 2 (TRAF2) and the 'undruggable' N-terminal region of β-catenin, a novel approach to inhibit the Wnt/β-catenin signaling in CRC [201].